Scinai Immunotherapeutics Ltd. Get Scinai Immunotherapeutics alerts:Read Our Latest Analysis on Scinai ImmunotherapeuticsHedge Funds Weigh In On Scinai ImmunotherapeuticsScinai Immunotherapeutics Trading Down 5.8%An institutional investor recently raised its position in Scinai Immunotherapeutics stock. Citadel Advisors LLC owned about 0.90% of Scinai Immunotherapeutics worth $36,000 at the end of the most recent reporting period. Scinai Immunotherapeutics has a 1 year low of $0.61 and a 1 year high of $6.18. Featured ArticlesReceive News & Ratings for Scinai Immunotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scinai Immunotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.